Abstract LB-B33: Nonclinical safety evaluation of two distinct second generation variants of anti-CTLA4 monoclonal antibody, ipilimumab, in monkeysKaren Price, Michael J. Graziano, Helen G. Haggerty et al.|Molecular Cancer Therapeutics|2018Cited by 11